Cargando…
RNA and nanocarriers: next generation drug and delivery platform take center stage
The unprecedented rapid deployment of mRNA vaccines against COVID-19 can be traced back to the early studies of RNA nanocarriers, including the study by Zimmermann et al. which showcased the effectiveness of RNA nanocarriers in vivo. This study, among others, ultimately resulted in Onpattro, the fir...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811353/ https://www.ncbi.nlm.nih.gov/pubmed/36609034 http://dx.doi.org/10.1016/j.tibtech.2022.12.019 |